The Newark, New York-based Ultralife Corp. was founded in 1990. It engages in the manufacturing and sale of products for power stations. Primarily operating through battery & energy products, along with communication systems segments. They majorly serve governments, defense and commercial customers worldwide. The company is about to announce its earnings on March 2, 2023.
Ultralife Corporation will report its Q4 earnings on March 2, 2023. The delay was said to be due to health issues experienced by some accounting firm members, thereby causing the delay. They will host an investor conference call and a webcast at 8:30 AM ET on March 2, 2023.
Holding a share for a longer period may or may not be profitable. ULBI holders have started to rethink their decision to hold, as it is down by 47% over half a decade. Last year also it performed badly, with a 23% correction in price. Last 5 years, the Earnings per Share (EPS) significantly dropped, and the share price remained at the lower end of the spectrum.
The above chart shows a considerable earnings portion below $0 and a continuous decline in the earrings for quite some time. The investors are not making money in the long term, and all hopes are on the next earning date of March 2, 2023.
At the time of writing, the power solutions company stocks were trading at $4.04 with a jump of 0.25%. Previous close and open were at $4.03 and $4.05; the fifty-two-week change is negative, 27.21%. The market cap is $65.17 million; at the same time, the volume was just 7,011 shares, and the average volume was 14,872 shares. The short interest seemed healthy, with 0.21% float sold short.
The company’s revenue was $119.5 million, while revenue per was at $7.42, and the quarterly revenue growth was 52.70%.
An overview of the chart indicates a consolidation phase, and the price is stuck between the supply and demand zones. The expected EPS at the earnings is $0.09; if the report fulfills this and the overall criteria assumed by the investors, the price might move north toward the supply zone. The price can move south to the demand zone if it fails to deliver.
A soft resistance can be assumed at the $4.23 mark; going up might consolidate between this mark and the supply zone. Very promising earnings coupled with some positive news can cause a breakthrough in the supply zone.
Soft support can be assumed to sit at the $3.94 mark; the price could bounce off from it and consolidate further if the current scenario continues. A bad earnings report can break this mark before consolidating near the demand zone. The southward breakthrough of the demand zone is highly unlikely, as it is also a very strong support. Only a piece of very bad news can cause this.
Source: https://www.thecoinrepublic.com/2023/03/01/ultralife-corp-ulbi-can-new-earnings-beat-5-year-eps-drought/